Continued pressure on NHS bed space and waiting lists creates an attractive opportunity for the drug industry to facilitate the treatment of patients at home. One way of achieving this is to consider investing a little more in your product development programmes, for example by utilising patient-friendly syringes or ready-to-use fixed rate infusions. In addition, review your existing portfolio to see if you have any candidates for home care. Home therapy often brings improved patient compliance, maximising therapeutic outcome and patient quality of life as well as minimising drug wastage.

Central Homecare has a proven track record of working with pharmaceutical companies in delivering both patient-centred home care services and specialist wholesaling. We are an established provider of high-tech services to patients requiring management of either simple or complex drug therapies in their own homes and provide an extensive range of ambulatory drug infusion systems, consumable equipment and comprehensive aseptic drug compounding services.

Central Homecare has the technology to bring you closer to patients, giving you the competitive advantage.

Central Homecare has already built long term relationships with a number of pharmaceutical companies, for example Pharmacia and Pfizer concerning the distribution of growth hormone to patients at home. More recently, Central Homecare has concluded an agreement with medac GmbH to distribute Metoject pre-filled syringes (methotrexate 10mg/mL) to patients at home in the UK

Central Homecare is an ISO 9001:2000 accredited company so service quality is assured.